Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Hepion Pharmaceuticals, Inc. (HEPA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6619-0.0293 (-4.24%)
At close: 03:47PM EDT
0.6600 -0.00 (-0.29%)
After hours: 04:26PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • T
    Thomas
    Some must of swooped up 20,000 shares. This caused a shift in price.
  • R
    RoidRage
    No dilution from voting. Most people were against 200Mio pcs. But the actual dates for Ph2b are far away... Q3 2023 and 2025 for Reconfilstat... Think this will bobbing around for some more month/years
  • s
    scamman
    Maybe instead of begging shareholders to let themselves get screwed maybe show shareholders that management believes in the future by buying some shares at market!
  • E
    Elvis
    I still believe in HEPA and think price is really cheap now. Also, this microcap supported by early study could have diabetes breakthrough.
    https://richardacavalli.wixsite.com/greenplanetmicrocaps/new-diabetes-treatment
  • T
    THOMAS
    How low can this stock go?
    Bearish
  • T
    Thomas
    Heads up. With positive results in p2, we will have to approve increased shares to fund a p3. No P3, No Hepion. Hepion we need positive data. No positive data will result in no Hepion. We will all loose our money

    Hepion, I am sure that you are reading this. Give us a bone. We need positive p2 news. With positive p2 news, I will beg our share holders to approve to approve new shares.

    It is scratch my back: I will scratch your back.

    Who is on board for this?

    Give me a thumbs up!
  • T
    Thomas
    It looks like there is only day trading in this stock. People who see that P2 will be will be great hold this stock long, less taxes. Very little of the stock is held short. I will not buy more because I don't put all my eggs in one basket. The stock price is going to go to the moon, or the company will go bankrupt. Positive p2 will provide the answer.
  • X
    Xike
    Where’s the link that says they delay P2b into 2023? They’re supposed to do it this year? What’re they doing now, sitting around doing nothing?
  • Z
    Ziaullah
    Sorry for those invistor that still believe in this scam
    Bearish
  • s
    scamman
    Down 70% in 1 year yet management thinks they deserve a "omnibus" package of benefits? They should be getting rid of their benefits and cuts in wages with the dismal state of stock!!!
  • X
    Xike
    Higher volume than usual!
  • X
    Xike
    When are we going to get a break for this stock? Or it’s just kept getting hammered like this?
  • G
    G
    Invested here but don't follow this as close as other stocks. Is thromboembolic disorder a disease Hepion has targeted in their pipeline? They recently submitted US patent application 20220168385 for this.
  • s
    scamman
    Surprise surprise, Foster delays the meeting because grumpy broke shareholders wont ok his "omnibus incentive plan" Jesus I wonder why stock is at or near all time low .....
  • T
    Thomas
    Today only 1.14 million shares are held short... That is 1.5%. Compare that to Ford at 2.99%.
    A few people can make the stock price swing up and down. I suspect that if I tried to buy 100,000 shares: The price would go to over $5 a share because there would be a feeding frenzy. I believe that this stock will pay off big in the next 2 years if liver test are positive. You need to read the research.
    I will not put all of my eggs in this basket because negative results will lead to Hepa bankruptcy.
    I believe that with good results phase 2. This stock will be at over $100 a share.
  • T
    Thomas
    Today’s price is irrelevant
    It’s value will be realized with results in phase2
    With great news the stock price can shoot to the moon
    With bad news, we could loose all our money
    Most of the stock is held long.
  • M
    Man in the Moon
    Something have to happen now, had some very positive news the last weeks and we have cash. Really hope HEPA got it straight back to over 1$ by itself...
  • C
    Cesars Palace
    Don't know...about to take my 20k loss and move on
  • M
    Man in the Moon
    Still here, still waiting
  • s
    scamman
    Can someone tell me about the latest proxy letter where HEPA wants to increase the outstanding shares but claim there will be no dilution for management “them” and “investors “, am I wrong in assuming they mean institutions but not regular shareholders in the no dilution statement? Looks like a nice play on words to not show how shareholders are getting the big F ing while they and there Wall Street buddies don’t lose a bit!
Advertisement
Advertisement